Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Principles of therapy for tuberculosis

L Ortona1, A Antinori

  • 1Istituto di Clinica delle Malattie Infettive, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Roma, Italy.

Rays
|July 22, 1998
PubMed
Summary

Tuberculosis treatment uses multi-drug, two-phase therapy for six months, with directly observed therapy (DOT) as a key strategy. For multidrug-resistant tuberculosis (MDR-TB), treatment involves 5-7 drugs and close monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bundibugyo virus disease: transmission dynamics, infectiousness and viral persistence.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments.

The Journal of antimicrobial chemotherapy·2025
Same author

Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
Same author

Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Cascade of care for TB infection in persons newly diagnosed with HIV in Italy.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.

The Journal of antimicrobial chemotherapy·2024

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Tuberculosis (TB) treatment relies on fundamental principles to combat the disease effectively.
  • A multi-drug approach is crucial to prevent and overcome drug resistance.
  • Two-phase therapy, involving an intensive initial phase followed by a continuation phase, is a cornerstone of current TB regimens.

Purpose of the Study:

  • To outline the standard and advanced therapeutic strategies for tuberculosis.
  • To detail the principles of multi-drug and two-phase therapy for TB.
  • To address the complexities of treating multidrug-resistant tuberculosis (MDR-TB).

Main Methods:

  • Standard six-month, two-phase regimens form the basis of current TB therapy.
  • Directly Observed Therapy (DOT) is utilized for intermittent drug administration, especially with compliant patients.
  • Initial treatment involves rifampicin, isoniazid, and pyrazinamide, with ethambutol or streptomycin added if isoniazid resistance exceeds 4%.

Main Results:

  • Standard therapy for most patients involves a six-month, two-phase protocol.
  • HIV-positive patients require a minimum of nine months of four-drug therapy.
  • Multidrug-resistant tuberculosis (MDR-TB) presents with unique clinical features, including higher mortality and cavitation rates.

Conclusions:

  • Treatment for MDR-TB requires careful consideration of prior therapy, susceptibility testing, patient compliance, and drug administration.
  • Regimens for suspected MDR-TB should include 5-7 drugs while awaiting susceptibility results.
  • Close clinical and bacteriological monitoring is essential for managing TB, particularly MDR-TB.

Related Experiment Videos